Market revenue in 2024 | USD 60.3 million |
Market revenue in 2030 | USD 85.9 million |
Growth rate | 6.1% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.66% in 2024. Horizon Databook has segmented the South Africa infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
The government of South Africa has made improvements in the country’s basic healthcare systems by providing free primary healthcare & diagnostic services to children & pregnant ladies. The South African government has also collaborated with the United Nations Organization to improve healthcare measures, thereby decreasing mortality rate and increasing life expectancy.
Several multinational companies, such as F. Hoffmann-La Roche Ltd., are focused on expanding their presence in the South African market by forming joint ventures with local companies, such as the Southern African Laboratory Diagnostics Association (SALDA).
SALDA represents laboratory medicine in Southern Africa and distributes molecular diagnostic tests in the country. These aforementioned factors are expected drive growth of the infectious diseases molecular diagnostics market in South Africa during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account